AKBA logoAKBA
Akebia Therapeutics Inc.

20,827
Loading...
Loading...
News
all
press releases
Akebia Therapeutics (AKBA) Reports Break-Even Earnings for Q2
Akebia Therapeutics (AKBA) delivered earnings and revenue surprises of +100.00% and +33.50%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
More News
News Placeholder
OmniAb, Inc. (OABI) Reports Q2 Loss, Lags Revenue Estimates
OmniAb, Inc. (OABI) delivered earnings and revenue surprises of -7.14% and -35.71%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Are Medical Stocks Lagging Akebia Therapeutics (AKBA) This Year?
Here is how Akebia Therapeutics (AKBA) and Alignment Healthcare (ALHC) have performed compared to their sector so far this year.
Zacks·2mo ago
News Placeholder
Akebia Therapeutics (AKBA) Upgraded to Strong Buy: Here's What You Should Know
Akebia Therapeutics (AKBA) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks·2mo ago
News Placeholder
Is Akebia Therapeutics (AKBA) Stock Outpacing Its Medical Peers This Year?
Here is how Akebia Therapeutics (AKBA) and ResMed (RMD) have performed compared to their sector so far this year.
Zacks·2mo ago
News Placeholder
Akebia Therapeutics (AKBA) Q1 Earnings and Revenues Top Estimates
chainwire·4mo ago
News Placeholder
Analysts Love These 2 Growth Stocks That Have Over 200% Upside Potential
Wall Street expects both of these biotech stocks to soar over 200% in the next 12 months.
barchart.com·6mo ago
News Placeholder
Akebia Therapeutics Announces Multiple Positive Business Updates
Akebia Therapeutics Announces Multiple Positive Business Updates Akebia Therapeutics Announces Multiple Positive Business Updates PR Newswire CAMBRIDGE, Mass., Jan. 13, 2025 New Commercial Supply...
PR Newswire·8mo ago
News Placeholder
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire CAMBRIDGE, Mass...
PR Newswire·9mo ago
News Placeholder
Akebia Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Akebia Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference Akebia Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference PR Newswire CAMBRIDGE, Mass...
PR Newswire·9mo ago

Latest AKBA News

View

Advertisement. Remove ads.

Advertisement. Remove ads.